DIA 2020 Global Annual Meeting

Agenda

Day 1 Jun 15, 2020

11:00 AM — 12:00 PM

To Shape the Future of Patient Labeling Across Regions

Day 2 Jun 16, 2020

8:00 AM — 9:00 AM

Patient-Centricity: How do We Measure Progress in Involving Patients in Drug Development and Drug Safety?

11:30 AM — 12:30 PM

Disruptive Transformation in Safety Organizations

2:00 PM — 3:00 PM

4:00 PM — 5:00 PM

FDA Pre-Market Safety Assessment Program

Day 3 Jun 17, 2020

11:30 AM — 12:30 PM

Report of CIOMS DILI Working Group

2:00 PM — 3:00 PM

4:00 PM — 5:00 PM

Immunogenicity of Biologics: Clinical Consequences

Day 4 Jun 18, 2020

8:00 AM — 9:00 AM

Digital Risk Minimization: How Can We Advance Adoption?

11:30 AM — 12:30 PM

Quantitative Benefit-Risk Assessment: What Methods are Being Used? How Far has Industry Come?

5:00 PM — 5:00 PM

ON DEMAND - Advancing Risk Management: What Can Evidence-Based Practices to Disseminate Healthcare Evidence into Practice Teach Us?

5:00 PM — 6:00 PM

ON DEMAND - Unblinding The New Face of the Local Safety Officer

5:00 PM — 6:00 PM

5:00 PM — 6:00 PM

ON DEMAND - The Opioid Epidemic: Top Ten Lessons in Regulatory Science

5:00 PM — 6:00 PM

ON DEMAND - What Does THAT Mean? Communicating Study Risks and Benefits in Patient-Friendly Language

Have an account?